Abushanab D - Search Results

1

Efficacy and safety of daratumumab for the treatment of refractory/relapsed multiple myeloma. A systematic review of meta-analyses.

Moustafa DA, Shafei L, Sulaiman R, Yassin MA, Abushanab D, Algarabli Y, Al-Badriyeh D. Moustafa DA, et al. Among authors: abushanab d. J Oncol Pharm Pract. 2024 Nov 21:10781552241290452. doi: 10.1177/10781552241290452. Online ahead of print. J Oncol Pharm Pract. 2024. PMID: 39569597 Review.

2

Cost-effectiveness analysis of genotype-guided optimization of major depression treatment in Qatar.

Abushanab D, Mohammed S, Abdel-Latif R, Al-Muftah W, Ismail SI, Al Hail M, Al-Marridi W, Abdallah O, Al-Khuzaei N, Al-Thani A, Al-Badriyeh D. Abushanab D, et al. J Pharm Policy Pract. 2024 Oct 25;17(1):2410197. doi: 10.1080/20523211.2024.2410197. eCollection 2024. J Pharm Policy Pract. 2024. PMID: 39469318 Free PMC article.

3

Cost-effectiveness of lowering systolic blood pressure in reducing cardiovascular disease burden in Australia.

Cho H, Lee J, Cao A, Leong GCW, Chenh K, Abushanab D, Marquina C, Ademi Z. Cho H, et al. Among authors: abushanab d. Curr Probl Cardiol. 2024 Dec;49(12):102859. doi: 10.1016/j.cpcardiol.2024.102859. Epub 2024 Sep 19. Curr Probl Cardiol. 2024. PMID: 39299366 Free article.

4

The Reduction of the Productivity Burden of Cardiovascular Disease by Improving the Risk Factor Control Among Australians with Type 2 Diabetes: A 10-Year Dynamic Analysis.

Abushanab D, Al-Badriyeh D, Marquina C, Morton JI, Lloyd M, Zomer E, Talic S, Liew D, Ademi Z. Abushanab D, et al. Eur J Prev Cardiol. 2024 Sep 6:zwae292. doi: 10.1093/eurjpc/zwae292. Online ahead of print. Eur J Prev Cardiol. 2024. PMID: 39238077

5

A cost-effectiveness analysis for high versus standard (low) dose caffeine for the treatment of apnea in neonatal intensive care unit.

Al-Hersh E, Abushanab D, AbouNahia F, Rainkie D, Al Hail M, Abdulrouf PV, El-Kassem W, Al-Badriyeh D. Al-Hersh E, et al. Among authors: abushanab d. J Pharm Policy Pract. 2024 May 22;17(1):2345218. doi: 10.1080/20523211.2024.2345218. eCollection 2024. J Pharm Policy Pract. 2024. PMID: 38798766 Free PMC article.

6

Epidemiology, clinical characteristics, and associated cost of acute poisoning: a retrospective study.

Salem W, Abdulrouf P, Thomas B, Elkassem W, Abushanab D, Rahman Khan H, Hanssens Y, Singh R, Zaki HA, Azad AM, Al Hail M, Mohammed S. Salem W, et al. Among authors: abushanab d. J Pharm Policy Pract. 2024 May 10;17(1):2325513. doi: 10.1080/20523211.2024.2325513. eCollection 2024. J Pharm Policy Pract. 2024. PMID: 38741897 Free PMC article.

7

Cardiac rehabilitation for participants with implantable cardiac devices: A systematic review and meta-analysis.

Kaddoura R, Al-Tamimi H, Abushanab D, Hayat S, Papasavvas T. Kaddoura R, et al. Among authors: abushanab d. Int J Cardiol Cardiovasc Risk Prev. 2024 Mar 14;21:200255. doi: 10.1016/j.ijcrp.2024.200255. eCollection 2024 Jun. Int J Cardiol Cardiovasc Risk Prev. 2024. PMID: 38737437 Free PMC article. Review.

8

Cost-effectiveness of l-glutamine versus crizanlizumab for adults with sickle cell disease: model focused on reducing pain episode costs from Qatar's healthcare perspective.

Adel AM, Abushanab D, Al-Badriyeh D, Hamad A, Alshurafa A, Yassin MA. Adel AM, et al. Among authors: abushanab d. SAGE Open Med. 2024 May 6;12:20503121231224551. doi: 10.1177/20503121231224551. eCollection 2024. SAGE Open Med. 2024. PMID: 38711465 Free PMC article.

9

The cost associated with the development of the antimicrobial stewardship program in the adult general medicine setting in Qatar.

Abushanab D, Al-Marridi W, Al Hail M, Abdul Rouf PV, ElKassem W, Thomas B, Alsoub H, Ademi Z, Hanssens Y, Enany RE, Al-Badriyeh D. Abushanab D, et al. J Pharm Policy Pract. 2024 Mar 27;17(1):2326382. doi: 10.1080/20523211.2024.2326382. eCollection 2024. J Pharm Policy Pract. 2024. PMID: 38549684 Free PMC article.

10

Efficacy and safety of selinexor for patients with relapsed and refractory multiple myeloma: A meta-analysis.

Shafei L, Bashir S, Chan EW, Abushanab D, Hamad A, Al-Badriyeh D. Shafei L, et al. Among authors: abushanab d. Curr Probl Cancer. 2024 Jun;50:101076. doi: 10.1016/j.currproblcancer.2024.101076. Epub 2024 Mar 26. Curr Probl Cancer. 2024. PMID: 38537395 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters